...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.
【24h】

Synthesis, crystal structure and biological evaluation of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives.

机译:新型2-(5-(羟甲基)-3-苯基-1H-吡唑-1-基)-1-苯基乙醇衍生物的合成,晶体结构和生物学评价。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel 2-(5-(hydroxymethyl)-3-phenyl-1H-pyrazol-1-yl)-1-phenylethanol derivatives (4) was synthesized from ethyl 1-(2-oxo-2-phenylethyl)-3-phenyl-1H-pyrazole-5-carboxylate derivatives (3) and characterized by means of IR, 1H NMR, HRMS and X-ray crystal diffraction. Structures of 4a, 4d, 4e and 4f were also determined by 13C NMR. Isomeric intermediates, 3a and 5a, were unambiguously confirmed by X-ray crystal structure analysis and successfully differentiated with 1H NMR chemical shifts of methylene bonded to pyrazole ring. Preliminary biological evaluation showed that compounds 4d and 4e could suppress A549 lung cancer cell growth through cell cycle arrest and autophagy.
机译:由乙基1-(2-氧代-2-苯基乙基)-3合成了一系列新型的2-(5-(羟甲基)-3-苯基-1H-吡唑-1-基)-1-苯基乙醇衍生物(4)。 -苯基-1H-吡唑-5-羧酸酯衍生物(3),并通过IR,1 H NMR,HRMS和X射线晶体衍射进行表征。还通过13 C NMR确定4a,4d,4e和4f的结构。 X射线晶体结构分析明确证实了异构体中间体3a和5a,并通过与吡唑环键合的亚甲基的1 H NMR化学位移成功地区分了异构体。初步生物学评估表明,化合物4d和4e可通过细胞周期阻滞和自噬抑制A549肺癌细胞的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号